Report overview
Pharma companies use IoT technologies in manufacturing plants to aid in the process of continuous manufacturing. Continuous manufacturing helps pharma companies to significantly cut cost and time in manufacturing and enhance product quality. IoT helps in the standardization of the manufacturing process along with data integrity. IoT provides visibility from production to distribution in a manufacturing plant, leading to better and feasible analysis of the processes thereby increasing operational efficiency.
This report aims to provide a comprehensive presentation of the global market for IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing. This report contains market size and forecasts of IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing in global, including the following market information:
Global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Medical Device Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing include PTC, Medtronic, Philips, Cisco Systems, IBM Corporation, GE Healthcare, Microsoft Corporation, SAP SE and Qualcomm Life, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing Market Segment Percentages, by Type, 2022 (%)
Medical Device
System and Software
Service
Connectivity Technology
Global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing Market Segment Percentages, by Application, 2022 (%)
Clinical Trials
Drug Disclosure
Drug Manufacturing
Drug Supply Chain
Global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
PTC
Medtronic
Philips
Cisco Systems
IBM Corporation
GE Healthcare
Microsoft Corporation
SAP SE
Qualcomm Life
Honeywell Life Care Solutions
Stanley Healthcare
Outline of Major Chapters:
Chapter 1: Introduces the definition of IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing, market overview.
Chapter 2: Global IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing market size in revenue.
Chapter 3: Detailed analysis of IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of IoT Spending for Connected Devices, Platforms, Digital Services in Pharmaceutical Manufacturing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
